Segal Lloyd Mitchell's Form 4 filing
Repare Therapeutics Inc. (RPTX) · filed Mar 14, 2025
- Accession no.
- 0001415889-25-008105
- Filed
- Mar 14, 2025
- Trade date
- Mar 12, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $24.1K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Segal Lloyd MitchellCIK 0001477123 | Director, Officer (PRESIDENT AND CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 12, 2025 | Common Shares | SSaleDisposed | −21,179 | $1.14 | −$24,144.06 | 124,394 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.